非缺血性心肌病的研究进展及治疗现状  

Research progress and treatment status of non-ischemic cardiomyopathy

作　　者：刘泽恩 郭建强[1] LIU Ze'en;GUO Jianqiang(Department of Cardiology,Affiliated Hospital of Inner Mongolia Medical University,Hohhot,Inner Mongolia 010000,China)

机构地区：[1]内蒙古医科大学附属医院心血管内科,内蒙古呼和浩特010000

出　　处：《中国临床研究》2024年第6期835-838,871,共5页Chinese Journal of Clinical Research

摘　　要：临床上把心脏扩大、心律失常和心力衰竭三者单独或同时存在为特征的心脏疾病称为心肌病。通常由冠状动脉粥样硬化病变引起的为缺血性心肌病,非缺血性心肌病与之不同,是指由非冠状动脉粥样硬化病变所致,可引起心力衰竭、心律失常、甚至猝死。但对其病因、诊断、治疗方法仍不甚明确,疗效有待进一步探索。本文分析了缺血性心肌病病因学、诊断方面,及当前药物及非药物治疗现状,为此类患者的早期预防提供更多参考资料,为临床上患者的诊断及治疗提供方向。Cardiomyopathy is a heart disease clinically characterized by enlargement of the heart,arrhythmia and heart failure alone or simultaneously.Ischemic cardiomyopathy is usually caused by coronary atherosclerotic lesions,but non-ischemic cardiomyopathy(NICM)is different.It is caused by non-coronary atherosclerotic lesions which can cause heart failure,arrhythmia,and even sudden death.However,the pathogeny,diagnosis and treatment methods of NICM are still unclear,and the efficacy needs to be explored further.The article analyzes the pathogeny,diagnosis,current status of drugs and non-drug treatment of NICM,aiming to provide more reference materials for the early prevention of patients with NICM and provide direction for the diagnosis and treatment of NICM.

关 键 词：非缺血性心肌病 扩张型心肌病 肥厚型心肌病 限制性心肌病 心脏再同步化治疗 骨髓干细胞移植 射频消融术 

分 类 号：R542.2[医药卫生—心血管疾病]